After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects esagonowsky Mon, 11/09/2020 […]

Phase III study of vaccine candidate involved 43,538 participants

In the quest to image exceedingly small structures and phenomenon with higher precision, scientists have been pushing the […]

Researchers at the University of Colorado Boulder are developing a wearable electronic device that’s “really wearable”- a stretchy […]

The title of Torjesen’s article, “BMA should drop its opposition to assisting dying, say members in landmark poll,”1 […]

The National Institute for Health and Care Excellence (NICE) is proposing placing more emphasis on “real world evidence” […]

Conclusions made by a group of experts from academia and industry

Approval is based on results from phase III THALES trial

Industry bodies respond to Specialised Committee outcome

New approval marks third indication for an Opdivo plus Yervoy-based regimen in the EU